The clinical safety and efficacy of EPLBD and ESLBD on large CBD stones treatment

The clinical study of EPLBD and ESLBD on large CBD stones treatment: a randomized, parallel control, single blind and single-center study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004496

Enrollment

Unknown

Registered

2014-01-27

Start date

2014-02-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CBD stone

Interventions

EPLBD group:EPLBD

ESLBD group:ESLBD

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged 18-70; routine intubation success, contrast find pure common bile duct stones and larger than 1cm; after Gallbladder surgery, or implement cholecystectomy recently proposed; subjects volunteered to participate in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: Coagulation dysfunction (INR>1.3); peripheral platelet count <50×10^9/L; patients with severe liver disease; biliary duct cancer or intrahepatic bile duct stones; combined bile duct stenosis; papilla impacted stones; after the success of the pre-cut cannula; intraoperative biliary fistula; undergo previous stone removed by EST or EPBD; patients with septic shock; poor compliance or determined substandard by a doctor; other ERCP contraindications; pregnancy

Design outcomes

Primary

Measure	Time frame
Short-term complication rate;	—

Secondary

Measure	Time frame
Complete clearance rate of stones;Reoperation rate;Stone recurrence rate;ERCP operating time;Stone removed time;	—

Countries

China

Contacts

Public ContactYunhong Li

Nanjing Drum Tower Hospital

13605156761@163.com+86 025-8330-4616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026